Similar Search Results

Narrow search

Challenges for corporate ethics in marketing genetic tests

Williams-Jones, Bryn; Ozdemir, Vural - In: Journal of business ethics : JOBE 77 (2008) 1, pp. 33-44

Persistent link: https://www.econbiz.de/10003672245

Challenges for Corporate Ethics in Marketing Genetic Tests

Williams-Jones, Bryn; Ozdemir, Vural - In: Journal of business ethics : JOBE 77 (2008) 1, pp. 33

Persistent link: https://www.econbiz.de/10007896625

Challenges for Corporate Ethics in Marketing Genetic Tests

Williams-Jones, Bryn; Ozdemir, Vural - In: Journal of business ethics : JOBE 77 (2008) 1, pp. 33-45

Persistent link: https://www.econbiz.de/10009030921

Challenges for Corporate Ethics in Marketing Genetic Tests

Williams-Jones, Bryn; Ozdemir, Vural - In: Journal of Business Ethics 77 (2008) 1, pp. 33-44

Persistent link: https://www.econbiz.de/10005547523

How do business model and health technology design influence each other? : insights from a longitudinal case study of three academic spin-offs

Lehoux, Pascale; Daudelin, G.; Williams-Jones, Bryn; … - In: Research policy : policy, management and economic … 43 (2014) 6, pp. 1025-1038

Persistent link: https://www.econbiz.de/10010472758

Anticipatory governance and moral imagination : methodological insights from a scenario-based public deliberation study

Lehoux, Pascale; Miller, Fiona A.; Williams-Jones, Bryn - In: Technological forecasting & social change : an … 151 (2020), pp. 1-13

Persistent link: https://www.econbiz.de/10012229702

Ethics and Genetics: Susceptibility Testing in the Workplace

Macdonald, Chris; Williams-Jones, Bryn - In: Journal of business ethics : JOBE 35 (2002) 3, pp. 235

Persistent link: https://www.econbiz.de/10006897829

Assessment of the impact of market regulation in Mali on the price of essential medicines provided through the private sector

Maïga, Diadié; Williams-Jones, Bryn - In: Health Policy 97 (2010) 2-3, pp. 130-135

Objective In 1998, the government of Mali adopted a national pharmaceutical policy aimed at promoting a supply system for generic essential medicines that would guarantee equal access for all citizens. Distribution and delivery is a shared responsibility of both public and private sectors...

Persistent link: https://www.econbiz.de/10008871760